Volume 33, Issue 4 (July 2022)
Studies in Medical Sciences 2022, 33(4): 283-290 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Naji S, Jafarpour Z, Vazifekhah S. EVALUATION OF SERUM LEVELS OF ANTIBODIES AGAINST CHLAMYDIA TRACHOMATIS IN THE WOMEN WITH RECURRENT MISCARRIAGE REFERRED TO THE PERINATOLOGY CLINIC OF SHAHID MOTAHARI HOSPITAL IN URMIA CITY, IRAN. Studies in Medical Sciences 2022; 33 (4) :283-290
URL: http://umj.umsu.ac.ir/article-1-5845-en.html
URL: http://umj.umsu.ac.ir/article-1-5845-en.html
Assistant Professor of Maternal and Child Obesity Research Center, Urmia University of Medical Sciences, Urmia, Iran (Corresponding Author) , shabnam.vazifekhah@yahoo.com
Abstract: (1973 Views)
Background & Aims: Since chlamydia trachomatis causes chronic infection of female urinary-genital tracts, it may play an effective role in in the occurrence of recurrent miscarriages. This study aims to determine the serum level of antibodies against Chlamydia trachomatis in women with recurrent miscarriages.
Materials & Methods: The present study is descriptive-analytical and cross-sectional. 76 patients diagnosed with recurrent miscarriages referred to the perinatology clinic of Shahid Motahari Hospital in Urmia, Iran were included in the study. The data was collected using a researcher-made checklist which its validity was approved by the women's group's professors and its reliability was obtained using Cronbach's alpha coefficient of 0.88. Chi-square test was used for analysis of qualitative and independent t-test for analysis quantitative variables. Data analysis was done using SPSS20 software. The significance level was considered less than 0.05.
Results: All 76 patients had positive values for IgG and IgM, and 89.48% of them had positive values of IgA antibodies against Chlamydia trachomatis. There was no significant relationship between the number of abortions, duration of the marriage, gestational age, use of contraceptive pills, and the serum level of antibodies against Chlamydia trachomatis (P>0.05). IgA against this organism in the women with a previous history of successful pregnancy was significantly higher than the women without it (P=0.01).
Conclusion: The positivity of all patients with a history of recurrent miscarriage in terms of serum IgG and IgM levels as well as their predominant positivity in terms of IgA indicates the impact of this infection on the abortion process in the patients.
Materials & Methods: The present study is descriptive-analytical and cross-sectional. 76 patients diagnosed with recurrent miscarriages referred to the perinatology clinic of Shahid Motahari Hospital in Urmia, Iran were included in the study. The data was collected using a researcher-made checklist which its validity was approved by the women's group's professors and its reliability was obtained using Cronbach's alpha coefficient of 0.88. Chi-square test was used for analysis of qualitative and independent t-test for analysis quantitative variables. Data analysis was done using SPSS20 software. The significance level was considered less than 0.05.
Results: All 76 patients had positive values for IgG and IgM, and 89.48% of them had positive values of IgA antibodies against Chlamydia trachomatis. There was no significant relationship between the number of abortions, duration of the marriage, gestational age, use of contraceptive pills, and the serum level of antibodies against Chlamydia trachomatis (P>0.05). IgA against this organism in the women with a previous history of successful pregnancy was significantly higher than the women without it (P=0.01).
Conclusion: The positivity of all patients with a history of recurrent miscarriage in terms of serum IgG and IgM levels as well as their predominant positivity in terms of IgA indicates the impact of this infection on the abortion process in the patients.
Type of Study: Research |
Subject:
زنان و زایمان
References
1. Choi TY, Lee HM, Park WK, Jeong SY, Moon HS. Spontaneous abortion and recurrent miscarriage: A comparison of cytogenetic diagnosis in 250 cases. Obstet Gynecol Sci 2014;57(6):518-22. [DOI:10.5468/ogs.2014.57.6.518] [PMID] [PMCID]
2. Saxena U. Association between Chlamydia trachomatis infection and recurrent pregnancy loss. Int J Reprod Contracept Obstet Gynecol 2022 Feb 1;11(2):557-63. [DOI:10.18203/2320-1770.ijrcog20220187]
3. Shaheen A, Yazaji H. Prevalence of Chlamydia Trachomatis among pregnant women. Tishreen Univ J Med Sci Series 2022;44(3):669-82 [Google Scholar]
4. Al-Nuaimy WA, Al-Jandeel T. Immunological and molecular study of Chlamydia trachomatis as causative agent of abortion in Al-Muthanna province. Iraqi J Vet Sci 2018;42:99-104.
https://doi.org/10.30539/iraqijvm.v42i1.38 [DOI:10.30539/017]
5. Sixt BS, Valdivia RH, Kroemer G. Chlamydia trachomatis' struggle to keep its host alive. Microbol Cell 2017;4(3):101-9. [DOI:10.15698/mic2017.03.564] [PMID] [PMCID]
6. Bagheri S, Roghanian R, Golbang N, Golbang P, Esfahani MH. Molecular evidence of Chlamydia trachomatis infection and its relation to miscarriage. Int J Fertil Steril 2018;12(2):152. [PMCID]
7. Aitken I, Longbottom D. Chlamydial abortion. Obstet Gynecol 2010;4(16):105-12. [DOI:10.1002/9780470753316.ch16] [PMID]
8. Zahirnia Z, Eslami G, Goodarzi H, Taheri S, Fallah F, Taheripanah R, et al . Evaluation of the prevalence of infection with Chlamydia trachomatis in spontaneous abortions, by Nested PCR method. Res Med 2013;37(1):67-72. [URL]
9. Arsovic A, Nikolov A, Sazdanovic P, Popovic S, Baskic D. Prevalence and diagnostic significance of specific IgA and anti-heat shock protein 60 Chlamydia trachomatis antibodies in subfertile women. Eur J Clin Microbiol 2014;33(5):761-6. [DOI:10.1007/s10096-013-2008-4] [PMID]
10. Shetty S, Kouskouti C, Schoen U, Evangelatos N, Vishwanath S, Satyamoorthy K, Kainer F, Brand A. Diagnosis of Chlamydia trachomatis genital infections in the era of genomic medicine. Braz J Microbiol 2021;52(3):1327-39. [DOI:10.1007/s42770-021-00533-z] [PMID] [PMCID]
11. Ray A, Bhati T, Arora R, Pradhan D, Parvez S, Rastogi S. Differential expression of urine-circulating micro-RNAs in Chlamydia trachomatis-induced recurrent spontaneous aborters. Microb Pathog 2021;160:105156. [DOI:10.1016/j.micpath.2021.105156] [PMID]
12. Quinn P, Petric M, Barkin M, Butany J, Derzko C, Gysler M, et al. Prevalence of antibody to Chlamydia trachomatis in spontaneous abortion and infertility. Am J Obstet Gynecol 2004;156(2):291-6.
https://doi.org/10.1016/j.ajog.2003.08.004 [DOI:10.1016/0002-9378(87)90270-5] [PMID]
13. Rowland GF, Forsey T, Moss TR, Steptoe PC, Hewitt J, Darougar S. Failure of in vitro fertilization and embryo replacement following infection with Chlamydia trachomatis. J In Vitro Fert Embryo Transf 2008;2(3):151-5. [DOI:10.1007/BF01131503] [PMID]
14. SotoodehJahromi AR, Safa O, Zare SH. Anti-Chlamydia trachomatis antibodies and abortion in women referring to Shariati Hospital of Bandar Abbas. Med J Hormozgan Univ 2005;8(4):185-8. [URL]
15. Wilkowska-Trojniel M, Zdrodowska-Stefanow B, Ostaszewska-Puchalska I, Redzko S, Przepiesc J, Zdrodowski M. The influence of Chlamydia trachomatis infection on spontaneous abortions. Adv Med Sci 2009;54(1):86-95. [DOI:10.2478/v10039-009-0008-5] [PMID]
16. Rours GIJ, Duijts L, Moll HA, Arends LR, de Groot R, Jaddoe VW, et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. Europ J Epidemiol. 2011;26(6):493-502. [DOI:10.1007/s10654-011-9586-1] [PMID] [PMCID]
17. 17 Moaddab S R, Kazemi Haki B, Ebrahimi AtashKhosroo N. Investigation of genes responsible for vancomycin resistance by Multiplex-PCR among enterococci isolated strains from inpatients and outpatients. Med Sci 2015;24(4):227-34 [Google Scholar]
18. 18 Moaddab SR, Amini K, Haki BK. Determining the drug susceptibility of Mycobacterium tuberculosis strains to the pyrazinamide. Med J Tabriz Univ Med Sci 2015;37(3):56-62. [Google Scholar]
19. Branch DW, Heuser C. Recurrent miscarriage. Reproductive Endocrinology and Infertility. Eur J Epidemiol 2010;16(2):281-96. [DOI:10.1007/978-1-4419-1436-1_17] [PMCID]
20. Coomarasamy A, Dhillon-Smith RK, Papadopoulou A, Al-Memar M, Brewin J, Abrahams VM, Maheshwari A, Christiansen OB, Stephenson MD, Goddijn M, Oladapo OT. Recurrent miscarriage: evidence to accelerate action. Lancet 2021;397(10285):1675-82. [DOI:10.1016/S0140-6736(21)00681-4] [PMID]
21. Dobson SJ, Jayaprakasan KM. Aetiology of recurrent miscarriage and the role of adjuvant treatment in its management: a retrospective cohort review. J Obstet Gynaecol 2018;38(7):967-74. [DOI:10.1080/01443615.2018.1424811] [PMID]
22. Ali S, Majid S, Ali MN, Taing S, El-Serehy HA, Al-Misned FA. Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients. Saudi J Biol Sci 2020;27(10):2809-17. [DOI:10.1016/j.sjbs.2020.06.049] [PMID] [PMCID]
23. Van den Berg M, Vissenberg R, Goddijn M. Recurrent miscarriage clinics. Obstet Gynecol Clin 2014;41(1):145-55. [DOI:10.1016/j.ogc.2013.10.010] [PMID]
24. Daher S, Mattar R, Gueuvoghlanian‐Silva BY, Torloni MR. Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am J Reproduct Immunol 2012;67(4):341-7. [DOI:10.1111/j.1600-0897.2012.01123.x] [PMID]
25. Schwarzman P, Levy DP, Walfisch A, Sergienko R, Bernstein EH, Sheiner E. Maternal history of recurrent pregnancy loss and long-term risk of thromboembolic events. J Reprod Immunol 2020; 138:103084. [DOI:10.1016/j.jri.2020.103084] [PMID]
26. Khajeh Karam al-Dini Mehrangiz, Hashemi Seyed Ahmad, Naderi Nasab Mahboubeh, Meshkat Zahra, Saeed Jamedar. Prevalence of Chlamydia trachomatis infection in urethral and cervical specimens sent to Ghaem Hospital in Mashhad. Iran J Obstet Gynecol Infertil 2009; 13(6):17-21. [URL]
27. Al-Abbas WD, Radhi OA. Incidence of Chlamydia trachomatis and Trichomonas Vaginalis Genital Infections among Nonpregnant Women in Al-Najaf Province. Kufa J Nurs Sci 2019;9(1):1-8. [DOI:10.36321/kjns.vi20191.2251]
28. Mohllajee AP, Curtis KM, Martins SL, Peterson HB. Hormonal contraceptive use and risk of sexually transmitted infections: a systematic review. Contraception 2006;73(2):154-65. [DOI:10.1016/j.contraception.2005.08.012] [PMID]
29. Dos Santos LM, de Souza JD, Mbakwa HA, Nobre AF, Vieira RC, Ferrari SF, Rodrigues AR, Ishikawa EA, Guerreiro JF, de Sousa MS. High prevalence of sexual infection by human papillomavirus and Chlamydia trachomatis in sexually-active women from a large city in the Amazon region of Brazil. PloS One 2022;17(7):e0270874. [DOI:10.1371/journal.pone.0270874] [PMID] [PMCID]
30. Rugpao S, Sirirungsi W, Vannareumol P, Leechanachai P, Wongtrangarn S, Niyomka P, et al. Isolation of Chlamydia trachomatis among women with symptoms of lower genital tract infection. J Med Assoc Thailand 2010;76(9):475-81. [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
